Reimbursement changes or denial of coverage
Most revenue depends on Medicare and contracted third-party payors, so payment policy directly affects demand and realized revenue.
- Scope
- U.S. payor and CMS reimbursement
- Materiality
- high
iRhythm Holdings, Inc.
iRhythm Holdings, Inc. develops and commercializes ambulatory cardiac monitoring systems built around a wearable patch sensor and cloud-based ECG analytics. Its products are used to record heart rhythm data over extended periods so clinicians can detect and diagnose arrhythmias more efficiently, with sales concentrated in the United States and supported by smaller commercial footprints in Europe and Japan.
−4,9 %
70,6 %
−6,0 %
+26,2 %
4.63
4.48
| % | |
|---|---|
| Ambulatory cardiac monitoring systems | 100% Patch-based biosensors and related software used to capture and analyze ECG data over multiple days. |
iRhythm sells primarily to healthcare providers and healthcare systems that order ambulatory cardiac monitoring for...
- Physician practices and specialistsprimary
Cardiologists, electrophysiologists, neurologists, and other physicians order Zio monitoring to diagnose arrhythmias.
- Integrated delivery networks and health systemsprimary
Large provider networks adopt iRhythm for standardized, value-based cardiac monitoring workflows.
- Third-party payors and Medicareprimary
Commercial payors and CMS reimburse the monitoring service, shaping utilization and pricing.
- Hospitals and private physician practicessecondary
Some institutions purchase the service directly when they want outsourced ambulatory monitoring.
The United States is the core market and accounts for the vast majority of revenue. Outside the U.S...
- •United States is the main revenue base and operating center
- •UK market served through a direct sales and clinical team
- •Europe includes Switzerland, Austria, the Netherlands, and Spain
- •Japan is served through a third-party distributor
- •International markets are smaller but expand the addressable market
iRhythm’s strategy centers on expanding adoption of its patch-based monitoring platform among physicians, health...
01
Grow U.S. account base and utilizationshort-term
The business depends on recurring ordering by clinicians and health systems for monitoring volume.
02
Protect reimbursement and coding accessshort-term
Revenue is highly dependent on Medicare and commercial payor coverage and payment levels.
03
Expand international commercializationmedium-term
Europe and Japan provide additional growth avenues beyond the core U.S. market.
04
Differentiate through clinical workflow and analyticsmedium-term
Product performance, ease of use, and physician acceptance drive competitive wins.
iRhythm is exposed to reimbursement, regulatory, manufacturing, and supply-chain risks because its service depends on...
Medical-device regulatory and quality compliance
The biosensor and software are regulated products, and failures can trigger recalls, holds, or enforcement actions.
- Scope
- FDA, CE, PMDA and post-market surveillance
- Materiality
- high
Supply-chain and manufacturing disruption
The company relies on third-party vendors and some critical components have limited alternative sources.
- Scope
- Components and printed circuit board assembly
- Materiality
- high
Competitive pressure in remote cardiac monitoring
Large incumbents and regional providers compete on price, physician acceptance, and reimbursement access.
- Scope
- Holter monitors, event monitors, remote monitoring peers
- Materiality
- medium
International expansion execution risk
Operating outside the U.S. introduces regulatory, political, and commercial complexity.
- Scope
- UK, Europe, Japan
- Materiality
- medium
Revenue recognition and contractual allowances
Affects net revenue and receivables
Seasonality in monitoring volumes
Quarter-to-quarter comparability
Provision for credit losses
Affects operating results and receivables
Inventory and PCBA valuation
Affects cost of revenue and assets
Lease impairment and contingent consideration
Affects operating expenses and liabilities
BIOTRICITY INC.
BTCY · Surgical & Medical Instruments & Apparatus
HeartSciences Inc.
HSCS · Finance Services
HeartBeam, Inc.
BEAT · Surgical & Medical Instruments & Apparatus
RHYTHM PHARMACEUTICALS, INC.
RYTM · Pharmaceutical Preparations
Rhythm Pharmaceuticals is a U.S.-based biopharmaceutical company focused on developing and commercializing therapies for rare genetic disorders of obesity and related metabolic diseases.
Medtronic plc
MDT · Electromedical & Electrotherapeutic Apparatus
Medtronic plc designs, manufactures, and sells medical technologies used to diagnose, treat, and manage chronic and acute conditions across the body.
iHeartMedia, Inc.
IHRT · Radio Broadcasting Stations
: 29/04/2026